Yahoo
NSE - Free Realtime Quote INR

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)

216.81 -0.58 (-0.27%)
As of 1:47:10 PM GMT+5:30. Market Open.
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
3,157,510 2,872,250 2,687,160 2,087,020 2,367,140
Cost of Revenue
-1,198,070 -1,046,680 -966,680 -801,330 -925,140
Gross Profit
1,959,440 1,825,570 1,720,480 1,285,690 1,442,000
Selling, General and Administrative Expenses
-792,330 -985,570 -960,550 -831,450 -907,980
Operation and Maintenance Expenses
-12,000 -12,000 -9,250 -5,710 -3,520
Depreciation, Amortization and Depletion
-90,540 -94,440 -81,310 -16,630 -11,750
Provision Expense/Write-Back
0 -- 0 -7,670 -200
Other Income/Expense, Operating
-551,400 -247,260 -239,970 -208,160 -175,250
Operating Income/Expenses
-1,434,270 -1,339,270 -1,291,080 -1,069,620 -1,098,700
Total Operating Profit/Loss
525,170 486,300 429,400 216,070 343,300
Total Net Finance Income/Expense
-10,540 107,150 66,870 77,780 30,150
Net Investment Income
-- -- -- 0 1,480
Irregular Income/Expenses
-23,140 -20,790 196,870 0 -31,300
Other Income/Expense, Non-Operating
112,270 2,520 5,450 4,840 4,460
Non-Operating Income/Expenses, Total
78,590 88,880 269,190 82,620 4,790
Pretax Income
603,760 575,180 698,590 298,690 348,080
Provision for Income Tax
-151,870 -144,360 -144,980 -74,060 -80,870
Net Income from Continuing Operations
451,891 430,820 553,610 224,630 267,210
Net Income after Extraordinary Items and Discontinued Operations
451,891 430,820 553,610 224,630 267,210
Non-Controlling/Minority Interests
10 -- -- -- --
Net Income after Non-Controlling/Minority Interests
451,901 430,820 553,610 224,630 267,210
Net Income Available to Common Stockholders
451,901 430,820 553,610 224,630 267,210
Diluted Net Income Available to Common Stockholders
451,901 430,820 553,610 224,630 267,210
Common Dividend per Share
2.50 2.50 2.50 -- --
Special Dividend per Share
1.50 1.50 -- -- --
Basic EPS
6.78 6.40 8.26 3.40 4.08
Diluted EPS
6.67 6.31 8.22 3.39 4.08
Basic Weighted Average Shares Outstanding
66,750.92 67,325.78 66,999.28 66,123.63 65,495
Diluted Weighted Average Shares Outstanding
67,795.91 68,229.64 67,330.91 66,299.17 65,495
Income Statement, Supplemental
3/31/2023 - 7/1/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: